Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $1.5M | $1.9M | $2.4M | $1.7M |
| Gross profit | $0 | −$1.5M | −$1.9M | −$2.4M | −$1.7M |
| Gross margin | — | — | — | — | — |
| R&D | $34.2M | $47.0M | $76.1M | $95.4M | $66.2M |
| Operating income | −$41.0M | −$63.6M | −$102.4M | −$142.4M | −$98.4M |
| EBITDA | −$32.1M | −$51.5M | −$85.3M | −$133.1M | −$97.2M |
| Net income | −$33.3M | −$53.9M | −$96.3M | −$140.4M | −$89.0M |
| Net margin | — | — | — | — | — |
| EPS (diluted) | -78.65 | -127.39 | -102.09 | -58.98 | -22.52 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds FRLN.
No tracked institution reports a position in FRLN as of their last filing.
| Execution date | Ratio |
|---|---|
| 2023-05-12 | 1-for-15reverse |
No one on the platform has traded FRLN yet.
| $22M |
| — |
| LMNLLiminal BioSciences Inc. | $8.50 | +0.12% | $28M | — |
| LSBLakeShore Biopharma Co., Ltd | $0.63 | +0.00% | $26M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$FRLN Freeline to Present New Data on its Gaucher and Parkinson’s Disease Programs at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting https://www.stocktitan.net/news/FRLN/freeline-to-present-new-data-on-its-gaucher-and-parkinson-s-disease-y80a9tno5fg3.html
View on StockTwits ↗$GANX GBA1 VALID TARGET $lly $frln (TAKEN OUT)...... $NBIX
View on StockTwits ↗$FRLN whats going to happen to the shares that ibown in the stock
View on StockTwits ↗$FRLN Acquisition of Freeline by Syncona Becomes Effective https://www.stocktitan.net/news/FRLN/acquisition-of-freeline-by-syncona-becomes-gxtyf1m0b3e1.html
View on StockTwits ↗$FRLN Disappointing to shareholders; but congratulations to Syncona! You are acquiring a company privately which I strongly believe will help a lot of people very soon.
View on StockTwits ↗$FRLN Freeline Shareholders Approve Acquisition by Syncona https://www.stocktitan.net/news/FRLN/freeline-shareholders-approve-acquisition-by-j8m5yw0lf1c2.html
View on StockTwits ↗$FRLN Shame on Freeline's board for listening to and accepting the 'Siren Song' of Syncona.
View on StockTwits ↗$AMBI $PTON $FRLN $LOGC @Stocktwits reported for scam spam
View on StockTwits ↗$FRLN: Syncona to acquire Freeline Therapeutics Holdings for $6.50/share for each Freeline ADR https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20231122073409FRLN
View on StockTwits ↗Freeline Therapeutics Holdings plc Files SEC Form 6-K $FRLN https://www.marketbeat.com/stocks/NASDAQ/FRLN/sec-filings/
View on StockTwits ↗$FRLN Syncona just got a Great Deal!! Shareholders Not!!
View on StockTwits ↗$TSLA $FRLN Analyst price target for today<< top-trading-community.stocktraders.live
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.